Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
StateWatch: Bill Review March 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
Indiana Legislature Passes Drug Formulary Bill
The Indiana legislature passed a drug formulary bill based on ODG Guidelines.
The New Repair Network
The repair network of today is not your grandfather’s or your father’s repair network; in fact it may not even be your older brother’s repair network. Vehicles are becoming more sophisticated with every new model that rolls off the production line. They’re no longer merely a mode of transportation—they’re complex computer networks on wheels.
Impact of Drug Formularies on Workers' Compensation State Laws
Interest in drug formularies has grown significantly in the past few years, coinciding with a greater concern over the opioid crisis. Texas and Ohio were pioneering states in the creation of drug formularies and several states have followed suit recently. Oklahoma, Washington, Ohio, Tennessee, California, Arizona and Texas all have statewide drug formularies; states including Massachusetts, Indiana, Pennsylvania and New York are currently considering or developing formularies.
Understanding Predictive Analytics For Workers' Compensation Data Analysis
As technology evolves, several key ideas continue to permeate our conversations. One of the most exciting topics in 2018 is the application of predictive analytics in insurance and claims handling in particular. Unlike many of the broader terms in the industry (i.e. artificial intelligence, big data and InsureTech), predictive analytics has specific and practical workflow applications today and continues to be an industry game changer.
Risk & Insurance: Treating Pain Without Drugs
From high praise to a spiraling crash, opioid-based pain medications are out of favor.